Healthcare investors go for full-body check-up: Forensic due diligence rise as sector faces scrutiny

Investors are increasingly scrutinizing India's healthcare sector, including pharma companies and hospitals, due to concerns about potential malpractices and regulatory scrutiny. They are conducting in-depth due diligence, examining doctor-management relationships, referral practices, and the appropriateness of treatments. This heightened scrutiny is driven by negative consumer feedback and stricter regulations, prompting companies to enhance employee background screening.